IART Integra LifeSciences Holdings

$14.73

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 10/2/2025

About Integra LifeSciences Holdings

Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, limb reconstruction, orthopedics, and general surgery. The company is headquartered in Princeton, New Jersey.

Website: https://www.integralife.com

Sector
LIFE SCIENCES
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
917520
Address
1100 CAMPUS ROAD, PRINCETON, NJ, US
Valuation
Market Cap
$1.22B
P/E Ratio
nan
PEG Ratio
0.80
Price to Book
0.79
Performance
EPS
$-0.09
Dividend Yield
—
Profit Margin
-0.43%
ROE
-0.44%
Technicals
50D MA
$21.81
200D MA
$22.50
52W High
$32.66
52W Low
$15.46
Fundamentals
Shares Outstanding
77M
Target Price
$24.75
Beta
1.25

IART EPS Estimates vs Actual

● Estimated
● Actual

IART News & Sentiment

Sep 22, 2025 • Benzinga SOMEWHAT-BULLISH
Integra LifeSciences Strengthens Leadership with Appointment of New Chief Medical Officer - Integra Lifesciences ( NASDAQ:IART )
PRINCETON, N.J., Sept. 22, 2025 ( GLOBE NEWSWIRE ) -- Integra LifeSciences Holdings Corporation IART today announced the appointment of Dr. Raymond Turner as its new corporate vice president and chief medical officer.
Sep 16, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Should You Continue to Hold Integra Stock in Your Portfolio Now?
IART shows strong demand in neurosurgery and Tissue Technologies but faces macro and liquidity challenges.
Aug 29, 2025 • GlobeNewswire SOMEWHAT-BULLISH
Integra LifeSciences Leadership to Present at Wells Fargo and Morgan Stanley Healthcare Investor Conferences
PRINCETON, N.J., Aug. 29, 2025 ( GLOBE NEWSWIRE ) -- Integra LifeSciences Holdings Corporation ( Nasdaq: IART ) , a leading global medical technology company, today announced that chief executive officer Mojdeh Poul and chief financial officer Lea Knight will present at two upcoming investor ...
Aug 29, 2025 • Benzinga SOMEWHAT-BULLISH
Integra LifeSciences Leadership to Present at Wells Fargo and Morgan Stanley Healthcare Investor Conferences - Integra Lifesciences ( NASDAQ:IART )
PRINCETON, N.J., Aug. 29, 2025 ( GLOBE NEWSWIRE ) -- Integra LifeSciences Holdings Corporation IART, a leading global medical technology company, today announced that chief executive officer Mojdeh Poul and chief financial officer Lea Knight will present at two upcoming investor healthcare ...
Aug 01, 2025 • Motley Fool SOMEWHAT-BULLISH
Integra ( IART ) Q2 Revenue Beats by 5%
Integra LifeSciences ( NASDAQ:IART ) , a medical technology company specializing in neurosurgery, reconstructive, and tissue technologies, released its results for Q2 2025 on July 31, 2025. The most important takeaway was that the company's revenue ( GAAP ) exceeded expectations, coming in at ...
Jul 31, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Integra LifeSciences ( IART ) Beats Q2 Earnings and Revenue Estimates
Integra (IART) delivered earnings and revenue surprises of +4.65% and +5.05%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Sentiment Snapshot

Average Sentiment Score:

0.320
50 articles with scored sentiment

Overall Sentiment:

Bullish

IART Reported Earnings

May 05, 2025
Mar 31, 2025 (Pre market)
0.0 Surprise
  • Reported EPS: $0.00
  • Estimate: $0.00
  • Whisper: —
  • Surprise %: 0.0%
Feb 26, 2025
Dec 31, 2024 (Pre market)
0.11 Surprise
  • Reported EPS: $0.97
  • Estimate: $0.86
  • Whisper: —
  • Surprise %: 13.4%
Nov 04, 2024
Sep 30, 2024 (Pre market)
0.02 Surprise
  • Reported EPS: $0.41
  • Estimate: $0.39
  • Whisper: —
  • Surprise %: 5.1%
Jul 29, 2024
Jun 30, 2024 (Pre market)
0.01 Surprise
  • Reported EPS: $0.63
  • Estimate: $0.62
  • Whisper: —
  • Surprise %: 1.6%
May 06, 2024
Mar 31, 2024 (Pre market)
0.0 Surprise
  • Reported EPS: $0.55
  • Estimate: $0.55
  • Whisper: —
  • Surprise %: 0.0%
Feb 28, 2024
Dec 31, 2023 (Pre market)
-0.01 Surprise
  • Reported EPS: $0.89
  • Estimate: $0.90
  • Whisper: —
  • Surprise %: -1.1%
Oct 25, 2023
Sep 30, 2023 (Pre market)
-0.02 Surprise
  • Reported EPS: $0.76
  • Estimate: $0.78
  • Whisper: —
  • Surprise %: -2.6%
Jul 26, 2023
Jun 30, 2023 (Post market)
0.14 Surprise
  • Reported EPS: $0.71
  • Estimate: $0.57
  • Whisper: —
  • Surprise %: 24.6%
Apr 26, 2023
Mar 31, 2023 (Pre market)
0.0 Surprise
  • Reported EPS: $0.74
  • Estimate: $0.74
  • Whisper: —
  • Surprise %: 0.0%

Financials